HomeCompareYGYIP vs ARCC

YGYIP vs ARCC: Dividend Comparison 2026

YGYIP yields 1000.00% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YGYIP wins by $18844438.65M in total portfolio value
10 years
YGYIP
YGYIP
● Live price
1000.00%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18844438.68M
Annual income
$15,746,803,993,532.36
Full YGYIP calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — YGYIP vs ARCC

📍 YGYIP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYGYIPARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YGYIP + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YGYIP pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YGYIP
Annual income on $10K today (after 15% tax)
$85,000.00/yr
After 10yr DRIP, annual income (after tax)
$13,384,783,394,502.51/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, YGYIP beats the other by $13,384,783,394,501.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YGYIP + ARCC for your $10,000?

YGYIP: 50%ARCC: 50%
100% ARCC50/50100% YGYIP
Portfolio after 10yr
$9422219.35M
Annual income
$7,873,401,996,766.75/yr
Blended yield
83.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

YGYIP
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-5.2
Piotroski
3/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YGYIP buys
0
ARCC buys
0
No recent congressional trades found for YGYIP or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYGYIPARCC
Forward yield1000.00%10.65%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$18844438.68M$24.5K
Annual income after 10y$15,746,803,993,532.36$1.14
Total dividends collected$18607754.73M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: YGYIP vs ARCC ($10,000, DRIP)

YearYGYIP PortfolioYGYIP Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$110,700$100,000.00$11,373$532.74+$99.3KYGYIP
2$1,153,028$1,034,579.44$12,608$279.46+$1.14MYGYIP
3$11,304,737$10,070,996.94$13,809$142.90+$11.29MYGYIP
4$104,376,400$92,280,331.11$15,042$72.20+$104.36MYGYIP
5$907,965,307$796,282,558.81$16,341$36.27+$907.95MYGYIP
6$7,445,190,031$6,473,667,152.78$17,732$18.18+$7445.17MYGYIP
7$57,576,798,154$49,610,444,821.11$19,231$9.10+$57576.78MYGYIP
8$420,166,535,918$358,559,361,892.40$20,851$4.55+$420166.52MYGYIP
9$2,894,985,686,808$2,445,407,493,376.48$22,605$2.28+$2894985.66MYGYIP
10$18,844,438,678,417$15,746,803,993,532.36$24,504$1.14+$18844438.65MYGYIP

YGYIP vs ARCC: Complete Analysis 2026

YGYIPStock

Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally. It operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. The company offers nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, health and wellness, packaged foods, lifestyle products, pet care, digital products, telecare health services, apparel and fashion accessories, and business lending products. It also produces and sells coffee products under the Café La Rica, Café Alma, Josie's Java House, Javalution Urban Grind, Javalution Daily Grind, and Javalution Royal Roast brands; and produces and markets a line of coffees under the JavaFit brand directly to consumers. In addition, it offers CBD oils from hemp stock. The company sells coffee and equipment to wellness and retirement communities, and various cruise lines and coffee service operators, as well as through distribution network. Youngevity International, Inc. also markets its products through a range of consumer Websites, such as youngevity.com; ygyi.com; heritagemakers.com; hempfx.com; clrroasters.com; cafelarica.com; javalution.com. The company was formerly known as AL International, Inc. and changed its name to Youngevity International, Inc. in July 2013. Youngevity International, Inc. was founded in 1996 and is headquartered in Chula Vista, California.

Full YGYIP Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this YGYIP vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YGYIP vs SCHDYGYIP vs JEPIYGYIP vs OYGYIP vs KOYGYIP vs MAINYGYIP vs HTGCYGYIP vs GBDCYGYIP vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.